Kisung Nam
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Year:
2026
Year:
2026
Background Data on associations between genetic predisposition to high blood pressure (BP) and hypertension and its complications in non‐European populations are limited. The current study investigated associations between polygenic risk scores (PRSs) for BP and risks of hypertension, cardiovascular disease, and chronic kidney disease in Northeast Asian populations. Methods A genome‐wide association study of systolic BP (SBP) and diastolic BP (DBP) was conducted using data from the KoGES (Korean Genome and Epidemiology Study). Results were meta‐analyzed using summary statistics from Biobank Japan to construct PRSs. Results Compared with a PRS in the lowest 5 percentiles, a PRS in the highest 5 percentiles was associated with an increased risk of hypertension (hazard ratio [HR], 2.44 [95% CI, 1.67–3.56] for PRS for SBP; and HR, 1.77 [95% CI, 1.20–2.62] for PRS for DBP) and earlier onset of hypertension (by a median of 8.5 years for PRS for SBP and 8.0 years for PRS for DBP). These associations remained significant when continuous PRS was analyzed. The genetic risk of hypertension incidence was attenuated by moderate to vigorous physical activity. Adding the PRS for BP to the clinical risk factors improved the predictive value for hypertension (both area under the curve values, 0.787 [95% CI, 0.771–0.803]; P =0.063 for PRS for SBP and [95% CI, 0.771–0.804]; P =0.031 for PRS for DBP). However, neither PRS for SBP nor PRS for DBP was associated with the incidence of cardiovascular or chronic kidney disease. Conclusions The PRS for BP was associated with a higher risk of incident hypertension and earlier‐onset hypertension in a Northeast Asian population. PRS may facilitate early identification and targeted management of individuals at high risk of developing hypertension.
Year:
2026
Year:
2025
Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes’ functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.
Year:
2024
Due to their low frequency, estimating the effect of rare variants is challenging. Here, we propose RareEffect, a method that first estimates gene- or region-based heritability and then each variant effect size using an empirical Bayes approach. Our method uses a variance component model, popular in rare variant tests, and is designed to provide two levels of effect sizes, gene/region-level and variant-level, which can provide better interpretation. To adjust for the case-control imbalance in phenotypes, our approach uses a fast implementation of the Firth bias correction. We demonstrate the accuracy and computational efficiency of our method through extensive simulations and the analysis of UK Biobank whole exome sequencing data for 100 traits. Additionally, we show that the effect sizes obtained from our model can be leveraged to improve the performance of polygenic scores, outperforming recently developed methods for rare variant polygenic scoring.
Year:
2024
Large-scale whole-genome sequencing (WGS) data provides unprecedented opportunity to explore the role of rare variants in non-coding regions on complex traits. However, unlike gene-based exome analysis, non-coding regions lack a well-defined unit for rare-variant testing. Here, we utilized 1,036,913 candidate Cis-Regulatory Elements (cCREs) from ENCODE as analysis units and conducted rare-variant association analysis for 100 traits with SAIGE-GENE+. In a discovery set of 150K White-British samples we identified 1,987 significant associations and replicated 88% of them in a validation set of 250K White-British samples. Associations were enriched in promoter-like signals (PLS) and proximal enhancer- like signals (pELS). Conditional analyses of 230 cCREs across five traits on GWAS variants identified 68 independent cCRE associations. A leukemia case study highlighted key loci, including a PLS for SRSF2 and a pELS for BCL6, demonstrating the effectiveness of cCRE- based analysis.
Year:
2024
A meta-analysis is a practical approach to increasing the power of rare variant tests by combining summary statistics from multiple cohorts. However, existing methods for rare variant meta-analysis often fail to correctly control type I error rates when analyzing low-prevalence binary traits and are computationally intensive when analyzing many phenotypes. This paper introduces Meta-SAIGE, a novel approach for rare variant meta-analyses that addresses these challenges. Meta-SAIGE reduces type I error inflation through precise estimation of the distribution of test statistics and allows the reuse of the linkage disequilibrium (LD) matrix across phenotypes, significantly improving computational efficiency for phenome-wide analyses. Simulation studies using UK Biobank whole-exome sequencing (WES) genotypes demonstrate that Meta-SAIGE effectively controls type I error rates and yields power similar to that of pooled individual-level data through SAIGE-GENE+. A meta-analysis of UK Biobank and All of Us WES data for 83 low prevalence disease phenotypes identified 237 associations. Notably, 80 of these associations were not significant in either dataset alone, underscoring the power of our meta-analysis.
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Collaborators (43)
Xiaofeng Zhu
Professor
Case Western Reserve University
Harold Snieder
Scientific Staff
University Medical Center Groningen
Jin Man Kim
Assistant Professor
Seoul National University
Amy Bentley
National Human Genome Research Institute
Cristina Menni
King’s College London
Nicholas Wareham
Director
University of Cambridge
Joseph McCormick
James H. Steele Professor
-
Bhramar Mukherjee
-
Seunggeun Lee
Professor
Seoul National University
Dokyoon Kim
Assistant Professor
University of Pennsylvania
Vilmundur Gudnason
Professor
University of Iceland
Simon R. Cox
Personal Chair of Brain and Cognitive Ageing
University of Edinburgh
Jennifer Ann Smith
Professor
University of Michigan
Sarah Harris
University of Edinburgh
Ching-Ti Liu
Boston University
Ko Willems van Dijk
Professor
Leiden University Medical Center
massimo mangino
Honorary Senior Lecturer
King’s College London
Heming Wang
Assistant Professor
Brigham and Women's Hospital
Ilja Nolte
Senior Researcher of Statistical Genetics and Genetic Epidemiology
University Medical Center Groningen
Heather M Highland
University of North Carolina at Chapel Hill
Marcus Dörr
University Medicine Greifswald
Paul de Vries
Assistant Professor
The University of Texas Health Science Center at Houston School of Public Health
Lisa de las Fuentes
Professor of Medicine and Biostatistics
Washington University School of Medicine
Iris M. Heid
University of Regensburg
Rodney Scott
Prof. of Medical Genetics
University of Newcastle Australia
Myriam Fornage
-
Changwei Li
Associate Professor
University of Texas Southwestern Medical Center
Mary Feitosa
Associate Professor
Washington University School of Medicine
Debbie A Lawlor
Academic , Professor of Epidemiology, MRC Investigator and BHF Chair
University of Bristol
Sami Heikkinen
Research Director
University of Eastern Finland
Peter Y Liu
University of California
Kari North
Professor
University of North Carolina at Chapel Hill
Michael Province
Professor, Head Division of Statistical Genomics
Washington University in St. Louis
Uwe Völker
Professor, Head of Department
Universitätsmedizin Greifswald
Quan Sun
Research Assistant Professor
University of Pennsylvania
John Attia
University of Newcastle Australia
Sung-Jin Kim
Assistant Professr
Seoul National University
Nicholette Allred
Wake Forest Baptist Medical Center
Mariaelisa Graff
Assistant Professor
University of North Carolina
Brian Cade
Investigator
Brigham and Women's Hospital
Terho Lehtimäki
University of Tampere
SINA A. GHARIB
University of Washington
Jian'an Luan
University of Cambridge
Make your next move.
Prepare your application
Review drafts before you send them.